These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 15869707

  • 1. The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study.
    Herrera-Estrella M, Apiquian R, Fresan A, Sanchez-Torres I.
    BMC Psychiatry; 2005 May 03; 5():22. PubMed ID: 15869707
    [Abstract] [Full Text] [Related]

  • 2. Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?
    Blin O.
    Encephale; 2000 Oct 03; 26 Spec No 1():7-11. PubMed ID: 11294060
    [Abstract] [Full Text] [Related]

  • 3. Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.
    Kim SW, Shin IS, Kim JM, Yang SJ, Hwang MY, Yoon JS.
    J Clin Psychopharmacol; 2008 Jun 03; 28(3):349-52. PubMed ID: 18480697
    [No Abstract] [Full Text] [Related]

  • 4. Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group.
    Danion JM, Rein W, Fleurot O.
    Am J Psychiatry; 1999 Apr 03; 156(4):610-6. PubMed ID: 10200742
    [Abstract] [Full Text] [Related]

  • 5. Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
    Zink M, Knopf U, Henn FA, Thome J.
    Pharmacopsychiatry; 2004 Jan 03; 37(1):26-31. PubMed ID: 14750045
    [Abstract] [Full Text] [Related]

  • 6. [Evaluation of efficacy and tolerance of amisulpride in treatment of schizophrenic psychoses].
    Chabannes JP, Pelissolo A, Farah S, Gerard D.
    Encephale; 1998 Jan 03; 24(4):386-92. PubMed ID: 9809244
    [Abstract] [Full Text] [Related]

  • 7. [Effectiveness and tolerability of amisulpride in patients with schizophrenia: results of a 6-month open study].
    Rzewuska M, Kuczyński W, Luks M.
    Psychiatr Pol; 2004 Jan 03; 38(3):453-68. PubMed ID: 15199655
    [Abstract] [Full Text] [Related]

  • 8. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B, Hoogenboom G.
    Australas Psychiatry; 2004 Mar 03; 12(1):74-6. PubMed ID: 15715745
    [Abstract] [Full Text] [Related]

  • 9. Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis.
    Psarros C, Theleritis CG, Paparrigopoulos TJ, Politis AM, Papadimitriou GN.
    Int J Geriatr Psychiatry; 2009 May 03; 24(5):518-22. PubMed ID: 19072747
    [Abstract] [Full Text] [Related]

  • 10. How do we choose between atypical antipsychotics? The advantages of amisulpride.
    Mortimer AM.
    Int J Neuropsychopharmacol; 2004 Mar 03; 7 Suppl 1():S21-5. PubMed ID: 14972081
    [Abstract] [Full Text] [Related]

  • 11. Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.
    Leucht S, Pitschel-Walz G, Engel RR, Kissling W.
    Am J Psychiatry; 2002 Feb 03; 159(2):180-90. PubMed ID: 11823257
    [Abstract] [Full Text] [Related]

  • 12. Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study.
    Müller MJ, Regenbogen B, Sachse J, Eich FX, Härtter S, Hiemke C.
    Pharmacopsychiatry; 2006 Mar 03; 39(2):41-6. PubMed ID: 16555163
    [Abstract] [Full Text] [Related]

  • 13. Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials.
    Leucht S.
    Int J Neuropsychopharmacol; 2004 Mar 03; 7 Suppl 1():S15-20. PubMed ID: 14972080
    [Abstract] [Full Text] [Related]

  • 14. Amisulpride: a review of its efficacy in schizophrenia.
    Möller HJ.
    Acta Psychiatr Scand Suppl; 2000 Mar 03; 400():17-22. PubMed ID: 10823307
    [Abstract] [Full Text] [Related]

  • 15. Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study.
    Delcker A, Schoon ML, Oczkowski B, Gaertner HJ.
    Pharmacopsychiatry; 1990 May 03; 23(3):125-30. PubMed ID: 1973843
    [Abstract] [Full Text] [Related]

  • 16. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP, Spina E, Murray S, Yang R.
    Int Clin Psychopharmacol; 2006 May 03; 21(3):143-51. PubMed ID: 16528136
    [Abstract] [Full Text] [Related]

  • 17. Clinical update on amisulpride in deficit schizophrenia.
    Rein W, Turjanski S.
    Int Clin Psychopharmacol; 1997 May 03; 12 Suppl 2():S19-27. PubMed ID: 9218164
    [Abstract] [Full Text] [Related]

  • 18. Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial.
    Bhowmick S, Hazra A, Ghosh M.
    Aust N Z J Psychiatry; 2010 Mar 03; 44(3):237-42. PubMed ID: 20050717
    [Abstract] [Full Text] [Related]

  • 19. THE LESSA (Lebanese Short-term Study with Amisulpride) STUDY a Phase IV clinical trial in acutely ill schizophrenic patients.
    Baddoura R, Ourgandjian H.
    J Med Liban; 2004 Mar 03; 52(2):78-85. PubMed ID: 15884686
    [Abstract] [Full Text] [Related]

  • 20. Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.
    Müller MJ, Wetzel H, Eich FX, Rein W, Puech A, Benkert O, Amisulpride Study Group.
    J Clin Psychopharmacol; 2002 Dec 03; 22(6):554-60. PubMed ID: 12454554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.